Rootpath Genomics

Developer of immunotherapy platform for the treatment of cancer

placeCambridge, Massachusetts, United States calendar_todayFounded 2017 groups16 employees language rootpath.com

Registered entities

Innovation

11 patent families (3 granted) — focus: Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 895 times.

YearFilings
20194
20203
20217
20226
20237
20243
20251

Investor mix

10 investors on record; lead investors include Yuanhe Holdings, Sequoia Capital, CDH, Sky9 Capital.

Investor typeCountShare
Venture capital550%
Private equity220%
Accelerator & incubator110%
Other / undisclosed220%
Coming soon